Healthcare outlook rests on vaccine rollout
Many healthcare companies were seriously disrupted while dealing with the fallout from COVID-19. As vaccines get rolled out, momentum is likely to return.
In a year that has been so heavily dominated by healthcare due to the COVID-19 outbreak, there are many more health company losers than winners, with many being severely disrupted.
So says Yarra Capital Management head of small caps Katie Hudson. ASX heavyweights ResMed, CSL and Ramsay Health Care have suffered as the virus swept the world last year: ResMed lost out on new patient diagnoses for sleep apnoea (despite ventilator sales surging); CSL's plasma donations slowed; and Ramsay's hospitals were commandeered by governments as elective surgeries stopped for a period.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Personal finance
Fetching latest articles